Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2015 | 1 |
2021 | 1 |
2023 | 0 |
Search Results
3
results
Results by year
Page 1
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial.
Lancet Respir Med. 2021 Jun;9(6):585-592. doi: 10.1016/S2213-2600(20)30362-3. Epub 2021 Jan 27.
Lancet Respir Med. 2021.
PMID: 33515500
Clinical Trial.
Hypersensitivity pneumonitis caused by occupational exposure to phytase.
van Heemst RC, Sander I, Rooyackers J, de Jong L, Djamin RS, Aerts JG, Belderbos HN.
van Heemst RC, et al.
Eur Respir J. 2009 Jun;33(6):1507-9. doi: 10.1183/09031936.00035408.
Eur Respir J. 2009.
PMID: 19483053
Free article.
Item in Clipboard
Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer.
Mellema WW, Masen-Poos L, Smit EF, Hendriks LE, Aerts JG, Termeer A, Goosens MJ, Smit HJ, van den Heuvel MM, van der Wekken AJ, Herder GJ, Krouwels FH, Stigt JA, van den Borne BE, Haitjema TJ, Staal-Van den Brekel AJ, van Heemst RC, Pouw E, Dingemans AM.
Mellema WW, et al. Among authors: van heemst rc.
Lung Cancer. 2015 Nov;90(2):249-54. doi: 10.1016/j.lungcan.2015.09.012. Epub 2015 Sep 15.
Lung Cancer. 2015.
PMID: 26415993
Item in Clipboard
Cite
Cite